Published in Cancer Weekly, March 28th, 2006
The name change of Procyon Biopharma Inc. to Ambrilia Biopharma Inc. and the future share consolidation were also approved by Procyon' shareholders.
Following the closing of the acquisition and concurrent financing, the name of Procyon Biopharma Inc. will be changed to Ambrilia Biopharma Inc. and its shares will continue to trade on the Toronto Stock Exchange under the new ticker symbol AMB.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.